MVP Share Price

Open 4.30 Change Price %
High 4.74 1 Day 0.36 8.47
Low 4.30 1 Week 0.34 7.96
Close 4.61 1 Month -0.14 -2.95
Volume 202101 1 Year 1.07 30.23
52 Week High 6.85
52 Week Low 2.85
MVP Important Levels
Resistance 2 5.02
Resistance 1 4.85
Pivot 4.55
Support 1 4.37
Support 2 4.20
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TEG 0.05 0.00%
TEG 0.05 0.00%
TEG 0.05 0.00%
AKK 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
IMU 0.02 100.00%
IMU 0.02 100.00%
PMQ 0.03 50.00%
ARD 0.03 50.00%
ARD 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
EXG 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
SRX 16.00 -37.23%
SRX 16.00 -37.23%
More..

Medical Developments Inte (ASX: MVP)

MVP Technical Analysis 3
As on 9th Dec 2016 MVP Share Price closed @ 4.61 and we RECOMMEND Sell for LONG-TERM with Stoploss of 5.21 & Sell for SHORT-TERM with Stoploss of 4.90 we also expect STOCK to react on Following IMPORTANT LEVELS.
MVP Target for December
1st Target up-side 4.98
2nd Target up-side 5.4
3rd Target up-side 5.82
1st Target down-side 3.8
2nd Target down-side 3.38
3rd Target down-side 2.96
MVP Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.medicaldev.com
MVP Address
MVP
Factory 6
56 Smith Road
Springvale, VIC 3171
Australia
Phone: 61 3 9547 1888
Fax: 61 3 9547 0262
MVP Latest News
Interactive Technical Analysis Chart Medical Developments Inte ( MVP ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Medical Developments Inte
MVP Business Profile
Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment in Australia, New Zealand, Eastern Europe, Germany, Canada, the Middle East, and South America. It provides Penthrox, a non-narcotic inhalational analgesic that is self-administered by conscious haemodynamically stable patients through the hand-held inhaler to provide emergency pain relief. The company also offers asthma medical devices, including space chamber plus autoclavable, space chamber plus compact antistatic, and space chamber plus combo pack; and other medical devices, such as new face masks, emergency equipment bags, tourniquet, emergency medical consumables, and guedel airways. In addition, it provides rescue and resuscitation products; defibrillators; and veterinary equipment comprising anaesthetic machines, circuit vaporizers, breath–alert, KDK flowmeters, Easyfill systems, and KAB autoclavable bar and nipple attachments. The company sells its products through a network of industry specific distributors. Medical Developments International Limited is headquartered in Springvale, Australia.